Although many pharmacological functions, such as anti-inflammation, antioxidation, and prevention of myocardial fibrosis, had been reported to be responsible for the improvement of NGR1 to ischemic heart disease, there have been few research studies concerning the lipid metabolic regulation effect of NGR1 on ischemic heart disease. The gene discussed is RTN4R; the disease is coronary artery disorder.